Skip to main content

Want a detailed portfolio tracker?

Unicycive Therapeutics (UNCY) P/E (2021 - 2026)

Unicycive Therapeutics (UNCY) P/E from Jul 12, 2021 to Jul 21, 2026. The TTM Unicycive Therapeutics (UNCY) P/E is -2.97. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Unicycive Therapeutics (UNCY)

YearP/EChange
2026-2.97-29.97%
2025-4.24+199.98%
2024-1.41-54.33%
2023-3.09-41.01%
2022-5.25-80.44%
2021-26.82N/A

Comparison Unicycive Therapeutics (UNCY) P/E with competitors

Unicycive Therapeutics (UNCY) P/E is -2.97.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.14%
ENLVEnlivex Ltd0.07-102.52%
FGENFibroGen Inc0.24-108.09%
CHRSCoherus Biosciences Inc0.85-128.58%
FBIOFortress Biotech Inc0.95-131.97%
ORMPOramed Pharmaceuticals Inc1.50-150.63%
AGENAgenus Inc3.01-201.37%
INVAInnoviva Inc3.15-206.24%
VXRTVaxart Inc3.55-219.57%
CRMDCorMedix Inc3.63-222.22%
CVACCureVac N.V.4.45-249.74%
GLPGGalapagos NV4.86-263.66%
SRPTSarepta Therapeutics Inc4.88-264.44%
ABEOAbeona Therapeutics Inc5.39-281.47%
ABUSArbutus Biopharma Corp5.60-288.48%
ZVRAZevra Therapeutics Inc5.89-298.30%
SPROSpero Therapeutics Inc6.23-309.79%
CGENCompugen Ltd6.31-312.67%
RIGLRigel Pharmaceuticals6.87-331.47%
SLXNSilexion Therapeutics Corp7.30-345.76%
OMEROmeros Corporation9.26-411.86%
AUPHAurinia Pharmaceuticals Inc9.58-422.85%
PLXProtalix BioTherapeutics Inc10.89-466.84%
ACADAcadia Pharmaceuticals Inc11.73-495.06%
TBPHTheravance Biopharma Inc12.26-513.03%
ADMAAdma Biologics Inc12.42-518.28%
HRMYHarmony Biosciences Holdings Inc13.82-565.51%
SABSSAB Biotherapeutics Inc14.14-576.15%
NAGENiagen Bioscience Inc14.82-599.12%
INCYIncyte Corp15.82-632.96%
REGNRegeneron Pharmaceuticals Inc15.86-634.11%
PBYIPuma Biotechnology Inc17.32-683.25%
CPRXCatalyst Pharmaceuticals Inc17.44-687.41%
EXELExelixis Inc17.54-690.74%
TGTXTG Therapeutics Inc18.97-738.84%
MDXGMimedx Group Inc20.55-792.28%
XOMAXOMA Royalty Corp22.87-870.52%
ARGXArgen X SE24.30-918.46%
CTMXCytomX Therapeutics Inc24.82-936.08%
XOMAOXOMA Royalty Corp25.34-953.72%
HALOHalozyme Therapeutics Inc25.62-963.12%
XOMAPXOMA Royalty Corp25.67-964.68%
VRTXVertex Pharmaceuticals Inc27.99-1042.98%
RPRXRoyalty Pharma plc - Class A28.69-1066.32%
SLNOSoleno Therapeutics Inc29.02-1077.36%
ASNDAscendis Pharma A/S30.09-1113.41%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1377.04%
APLSApellis Pharmaceuticals Inc39.02-1414.40%
BMRNBiomarin Pharmaceutical Inc42.21-1521.87%
KRYSKrystal Biotech Inc45.34-1627.36%
ONCBeiGene Ltd69.54-2442.42%
PHARPharming Group N.V.75.03-2627.18%
TECHBio-Techne Corp101.96-3534.39%
VCELVericel Corp109.92-3802.62%
ALNYAlnylam Pharmaceuticals Inc117.96-4073.57%
GMABGenmab140.29-4825.59%
TLXTelix Pharmaceuticals Ltd162.15-5562.00%
CORTCorcept Therapeutics Inc212.86-7269.95%